Harvard Bioscience price target lowered to $3 from $4.50 at Benchmark

finance.yahoo.com/news/harvard-bioscience-price-target-lowered-131438755.html

In This Article:
Benchmark lowered the firm’s price target on Harvard Bioscience (HBIO) to $3 from $4.50 and keeps a Speculative Buy rating on the shares. The outlook for end-user markets in biomedical research continues to be challenging due to uncertainty around China tariffs, NIH…

This story appeared on finance.yahoo.com, 2025-05-14 13:14:38.
The Entire Business World on a Single Page. Free to Use →